A detailed history of Baron Silver Stevens Financial Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Baron Silver Stevens Financial Advisors, LLC holds 2,379 shares of ABBV stock, worth $435,547. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,379
Previous 2,279 4.39%
Holding current value
$435,547
Previous $390,000 20.26%
% of portfolio
0.08%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$163.84 - $199.33 $16,384 - $19,933
100 Added 4.39%
2,379 $469,000
Q2 2024

Jul 18, 2024

SELL
$154.79 - $180.76 $39,626 - $46,274
-256 Reduced 10.1%
2,279 $390,000
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $100,846 - $114,905
631 Added 33.14%
2,535 $461,000
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $330,240 - $371,928
-2,400 Reduced 55.76%
1,904 $295,000
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $3,606 - $4,175
-27 Reduced 0.62%
4,304 $641,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $19,876 - $24,735
-150 Reduced 3.35%
4,331 $583,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $12,002 - $13,822
83 Added 1.89%
4,481 $714,000
Q4 2022

Jan 30, 2023

BUY
$138.31 - $165.87 $608,287 - $729,496
4,398 New
4,398 $711,000
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $44,726 - $56,862
325 Added 7.85%
4,467 $684,000
Q1 2022

May 03, 2022

BUY
$131.98 - $163.75 $316,752 - $393,000
2,400 Added 137.77%
4,142 $671,000
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $187,143 - $236,790
1,742 New
1,742 $235,000
Q1 2021

Apr 27, 2021

SELL
$102.3 - $112.62 $130,841 - $144,040
-1,279 Closed
0 $0
Q4 2020

Mar 19, 2021

BUY
$80.49 - $108.67 $102,946 - $138,988
1,279 New
1,279 $137,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Baron Silver Stevens Financial Advisors, LLC Portfolio

Follow Baron Silver Stevens Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baron Silver Stevens Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baron Silver Stevens Financial Advisors, LLC with notifications on news.